Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Asset Writedowns and Impairment (2010 - 2024)

Updated

Ani Pharmaceuticals' Asset Writedowns and Impairment came in at $767,000 for FY2025, down 89.9% from $7.6 million in FY2024.

Analysis

Ani Pharmaceuticals (ANIP) Asset Writedowns and Impairment (2010 - 2024) Analysis & Trends

Going back to FY2010, Ani Pharmaceuticals' Asset Writedowns and Impairment data covers 9 years.

  • Asset Writedowns and Impairment carries a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • The FY2025 figure represents the lowest annual Asset Writedowns and Impairment since FY2022.
  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $7.6 million in FY2024, $574,000 in FY2022 (-75.8%) and $2.37 million in FY2021 (+433.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.60 Mn
Sep 30, 2022 -1,000.00
Dec 31, 2021 2.37 Mn
Dec 31, 2020 341,000.00
Sep 30, 2020 100,000.00
Dec 31, 2019 75,000.00
Sep 30, 2010 286,000.00
API Access

Ani Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ANIP&period=max&api_key=YOUR_API_KEY